Impairment of calcitonin gene-related peptide-induced potentiation of cholinergic sweat secretion in patients with multiple system atrophy

Clinical Autonomic Research

Volumn 7, Issue 2, 1997, Pages 77-80

  Kumazawa, K ^a   Sobue, G ^b   Mitsuma, T ^a   Sugenoya, J ^a   Ogawa, T ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcitonin gene related peptide; Multiple system atrophy; Peptidergic regulation; Sweat gland

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; METHACHOLINE;

ADULT; AGED; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOREARM; HUMAN; HUMAN EXPERIMENT; INTRADERMAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORTHOSTATIC HYPOTENSION; PEPTIDERGIC NERVOUS SYSTEM; SHY DRAGER SYNDROME; SWEAT TEST; SWEATING;

EID: 0030904508     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02267750     Document Type: Article

References (16)

1. Tainio H, Vaalasti A, Rechardt L. The distribution of substance P-, CGRP-, galanin- and ANP-like immunoreactive nerves in human sweat glands. Histochem J 1987; 19: 375-380.
2. Lindh B, Haegerstrand A, Lundberg JM et al. Substance P-, VIP-and CGRP-like immunoreactivities coexist in a population of cholinergic postganglionic sympathetic nerves innervating sweat glands in the cat. Acta Physiol Scand 1988; 134: 569-570.
3. Lindh B, Lundberg JM, Hökfelt T. NPY-, galanin-, VIP/PHI-, CGRP-and substance P-immunoreactive neuronal subpopulations in cat autonomic and sensory ganglia and their projections. Cell Tissue Res 1989; 256: 259-273.
4. Kruger L, Silverman JD, Mantyh PW, Sternini C, Brecha NC. Peripheral patterns of calcitonin-gene-related peptide general somatic sensory innervation: cutaneous and deep terminations. J Comp Neurol 1989; 280: 291-302.
5. Kumazawa K, Sobue G, Mitsuma T, Ogawa T. Modulatory effects of calcitonin gene-related peptide and substance P on human cholinergic sweat secretion. Clin Auton Res 1994; 4: 319-322.
6. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985; 313: 54-56.
7. Fox RH, Hilton SM. Bradykinin formation in human skin as a factor in heat vasodilatation. J Physiol (Lond) 1958; 142: 219-232.
8. Lundberg JM, Anggard A, Fahrenkrug J, Hökfelt T, Mutt V. Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion. Proc Natl Acad Sci USA 1980; 77: 1651-1655.
9. Sugenoya J, Ogawa T. Characteristics of central sudomotor mechanism estimated by frequency of sweat expulsions. Jpn J Physiol 1985; 35: 783-794.
10. Kumazawa K, Sobue G, Mitsuma T, Ogawa T, Sugenoya J. Effect of aging on postganglionic sudomotor function in man. In: Yoshikawa M, Yono M, Tanabe H, eds. New Trends in Autonomic Nervous System Research. Amsterdam: Elsevier, 1991; 94-95.
11. Matthews MR. Autonomic ganglia in multiple system atrophy and pure autonomic failure. In: Bannister R, Mathias CJ, eds. Autonomic Failure, 3rd edn. Oxford: Oxford University Press, 1992; 593-621.
12. Cohen J, Low PA, Fealey R, Sheps S, Jiang N-S. Somatic and autonomic function in progressive autonomic failure and multiple system atrophy. Ann Neurol 1987; 22: 692-699.
13. Anand P, Bannister R, McGregor GP, Ghatei MA, Mulderry PK, Bloom SR. Marked depletion of dorsal spinal cord substance P and calcitonin gene-related peptide with intact skin flare responses in multiple system atrophy. J Neurol Neurosurg Psychiatry 1988; 51: 192-196.
14. Benarroch EE. Neuropeptides in the sympathetic system: presence, plasticity, modulation, and implications. Ann Neurol 1994; 36: 6-13.
15. Yamashita Y, Ogawa T, Ohnishi N, Imamura R, Sugenoya J. Local effect of vasoactive intestinal polypeptide on human sweat-gland function. Jpn J Physiol 1987; 37: 929-936.
16. Yamashita Y, Ogawa T, Sugenoya J, Ohnishi N, Natsume K, Imamura R. Effects of atrial natriuretic peptide on human sweating activity. The Autonomic Nervous System 1989; 26: 523-530.